Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT02610361
Title Study of the Safety and Pharmacokinetics of BGB-283 in Patients With Solid Tumors
Recruitment Completed
Gender both
Phase Phase I
Variant Requirements Yes
Sponsors BeiGene
Indications

Advanced Solid Tumor

Therapies

BGB-283

Age Groups: adult
Covered Countries NZL | AUS

Additional content available in CKB BOOST